|
JAMA Article Raises CTA Concerns  A recent article in the Journal for the American Medical Association estimated the cancer risk from CTA radiation exposure. The research data suggests that young women receiving CTA may be at a higher cancer risk later in life. To view a full copy of the article... |
|
PET Continuing Education Articles  The Discussions in PET Imaging continuing education series supported by GE Healthcare are available online. This informative series reviews the use of PET in a variety of settings, including oncology, myocardial perfusion, and Alzheimer's Disease.http://www.diagnosticimaging.com/dpi/ge/ |
|
PET Changes Therapy in Half the Cases PET centers in Australia collected data on whether the modality changed the management of patients with different types of cancers and other applications, including melanoma, colorectral carcinoma, ovarian cancer, brain tumors, epilepsy, and myocardial viability. The recently published data found that PET changed therapy management in 59% of patients, with the majority of the cases rated as high impact by physicians. Approximately 49% had a change in modality treatment. |
|
APhA Election Results  Congratulations to Steve Mattmuller (Chair-elect)and Eric Smith (New Practioner) for being elected as the new incoming officers for the APhA-APPM Nuclear Section. We know they will do a great job after taking office at the 2008 APhA meeting. Congratulations also go out to Dan Kennedy who was elected APPM President-Elect. |
|
Covidien Separates from Tyco  July 2, 2007. The healthcare division of Tyco International was spun off to form an independent company named Covidien. This includes the radiopharmaceutical company of Mallinckrodt Medical. It will take a while to get used to the name change! View the company press release.... |
|
Online Poll
"Will the sestamibi generic event have a positive or negative effect on your pharmacy workplace?"
|
